Daralyn Durie - 26 May 2021 Form 3 Insider Report for Singular Genomics Systems, Inc.

Role
General Counsel
Signature
/s/ Daralyn Durie
Issuer symbol
N/A
Transactions as of
26 May 2021
Net transactions value
$0
Form type
3
Filing time
26 May 2021, 20:29:00 UTC
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding OMIC Employee Stock Option (right to buy) 26 May 2021 Common Stock 350,000 $8.95 By Daralyn Durie Revocable Trust dated March 19, 1999 F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Option granted under the Singular Genomics Systems, Inc. 2016 Stock Plan. 30% of the option shares vest and become exercisable on March 1, 2022; 1/40th of the option shares vest and become exercisable monthly for 12 months thereafter; 1/60th of the option shares vest and become exercisable monthly for 24 months thereafter.
F2 The Reporting Person is trustee of Daralyn Durie Revocable Trust dated March 19, 1999 and has voting and dispositive power with respect to these shares.

Remarks:

Exhibit 24 - Power of Attorney